前立腺肥大症(BPH)の治療薬の世界市場:販売動向2018

【英語タイトル】Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2018

QYResearchが出版した調査資料(QYR80702186)・商品コード:QYR80702186
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:106
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、前立腺肥大症(BPH)の治療薬の世界市場について調査・分析し、前立腺肥大症(BPH)の治療薬のメーカー別販売量、市場シェア分析、種類別販売分析(α遮断薬、ホスホジエステラーゼ5阻害薬、5α-リダクターゼ阻害剤)、用途別販売分析(男性、女性)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、前立腺肥大症(BPH)の治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・前立腺肥大症(BPH)の治療薬市場概要
・前立腺肥大症(BPH)の治療薬のメーカー別販売量・メーカー別シェア
・前立腺肥大症(BPH)の治療薬の世界市場:種類別販売量(α遮断薬、ホスホジエステラーゼ5阻害薬、5α-リダクターゼ阻害剤)
・前立腺肥大症(BPH)の治療薬の世界市場:用途別販売量(男性、女性)
・前立腺肥大症(BPH)の治療薬の世界市場:地域別販売量・市場シェア
・前立腺肥大症(BPH)の治療薬の米国市場規模
・前立腺肥大症(BPH)の治療薬の中国市場規模
・前立腺肥大症(BPH)の治療薬の欧州市場規模
・前立腺肥大症(BPH)の治療薬の日本市場規模
・前立腺肥大症(BPH)の治療薬の東南アジア市場規模
・前立腺肥大症(BPH)の治療薬のインド市場規模
・前立腺肥大症(BPH)の治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・前立腺肥大症(BPH)の治療薬のコスト分析・価格動向
・前立腺肥大症(BPH)の治療薬の産業チェーン(サプライチェーン分析)
・前立腺肥大症(BPH)の治療薬のマーケティング戦略・販売チャネル、流通業者
・前立腺肥大症(BPH)の治療薬市場への影響要因分析
・前立腺肥大症(BPH)の治療薬の世界市場予測
・前立腺肥大症(BPH)の治療薬の米国市場予測
・前立腺肥大症(BPH)の治療薬の中国市場予測
・前立腺肥大症(BPH)の治療薬の欧州市場予測
・前立腺肥大症(BPH)の治療薬の日本市場予測
・前立腺肥大症(BPH)の治療薬の東南アジア市場予測
・前立腺肥大症(BPH)の治療薬のインド市場予測
・前立腺肥大症(BPH)の治療薬の種類別世界市場予測(α遮断薬、ホスホジエステラーゼ5阻害薬、5α-リダクターゼ阻害剤)
・前立腺肥大症(BPH)の治療薬の用途別世界市場予測(男性、女性)
...
【レポートの概要】

This report studies the global Benign Prostatic Hyperplasia (BPH) Drugs market status and forecast, categorizes the global Benign Prostatic Hyperplasia (BPH) Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Urology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control problems, kidney stones and prostate problems, among others. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Benign prostatic hyperplasia (BPH) is an enlarged prostate, which increases the size of the prostate gland. As the prostate gets enlarged, it may squeeze or partly block the urethra, resulting in significantly blocking urine flow. BPH is normal in the aging process of a male, caused by changes in hormone balance and cell-growth.
The increasing demand for Benign Prostatic Hyperplasia (BPH) Drugs drives the market. Three factors contributing to the growth of the global benign prostatic hyperplasia drugs market are growing geriatric male population, strong r&d and growing demand for alpha-blockers. The evolution of alpha-blockers therapy for BPH has focused on improving convenience and tolerability. Reversing signs and symptoms or preventing progression of the disease are the indications of treating BPH. Alpha-blockers are the most effective, least costly, and best tolerated of the drugs for relieving LUTS. Additionally, one driver in market is growing geriatric male population. The presence of a large population with BPH symptoms is expected to drive the market growth. The risk of BPH increases exponentially with the rise in the age of an individual. Approximately, 80% of men who reach 60 years and above have mild to strong symptoms of BPH. This disorder affects one in 38 individuals in the age group of 40-59 years; however, in the age group of 60-69 years, it affects one in 14 individuals. The BPH drugs market in the Americas accounted for the majority market share during 2016 and the market in this region is likely to experience a high growth rate during the estimated period. Factors such as the growing demand for urology-related disorders and the increasing rate of geriatric men population, will stimulate the demand for BPH drugs and fuel the market’s growth.
The global Benign Prostatic Hyperplasia (BPH) Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alpha-Blocker
Phosphodiesterase Type-5 Inhibitors
5-Alpha-Reductase Inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Men
Women

The study objectives of this report are:
To analyze and study the global Benign Prostatic Hyperplasia (BPH) Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Benign Prostatic Hyperplasia (BPH) Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia (BPH) Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Benign Prostatic Hyperplasia (BPH) Drugs Manufacturers
Benign Prostatic Hyperplasia (BPH) Drugs Distributors/Traders/Wholesalers
Benign Prostatic Hyperplasia (BPH) Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Benign Prostatic Hyperplasia (BPH) Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2018
1 Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Drugs by Product Category
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Alpha-Blocker
1.2.4 Phosphodiesterase Type-5 Inhibitors
1.2.5 5-Alpha-Reductase Inhibitors
1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Market by Application/End Users
1.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Men
1.3.2 Women
1.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Market by Region
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.4.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.4.4 China Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.4.5 Japan Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.4.7 India Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Drugs (2013-2025)
1.5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2025)

2 Global Benign Prostatic Hyperplasia (BPH) Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Competition by Players/Suppliers
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume and Value) by Type
2.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume and Value) by Region
2.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume) by Application

3 United States Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
3.1 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
3.1.1 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
3.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
4.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
4.1.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
4.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
5.1 China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
5.1.1 China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
5.2 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
6.1 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
6.1.1 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
6.2 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Benign Prostatic Hyperplasia (BPH) Drugs (Volume, Value and Sales Price)
8.1 India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2013-2018)
8.1.1 India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2013-2018)
8.2 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Benign Prostatic Hyperplasia (BPH) Drugs Players/Suppliers Profiles and Sales Data
9.1 Astellas Pharma
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Sanofi
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 ADC Therapeutics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Bayer HealthCare
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Bristol-Myers Squibb
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Valeant Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Endo Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Foresee Pharmaceuticals
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Benign Prostatic Hyperplasia (BPH) Drugs Maufacturing Cost Analysis
10.1 Benign Prostatic Hyperplasia (BPH) Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2025)
14.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price and Trend Forecast (2018-2025)
14.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price Forecast by Type (2018-2025)
14.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Comparison (K MT) by Type (2013-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Alpha-Blocker Product Picture
Figure Phosphodiesterase Type-5 Inhibitors Product Picture
Figure 5-Alpha-Reductase Inhibitors Product Picture
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Comparison (K MT) by Application (2013-2025)
Figure Global Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Application in 2017
Figure Men Examples
Table Key Downstream Customer in Men
Figure Women Examples
Table Key Downstream Customer in Women
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate (2013-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) of Key Players/Suppliers (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers
Figure 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Market Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share (K MT) by Type (2013-2018)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Market Share by Region (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate by Region in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Growth Rate by Region in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Region in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Market Share by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Application (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Application (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) and Growth Rate (2013-2018)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/MT) Trend (2013-2018)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Players (2013-2018)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2017
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Type (2013-2018)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2017
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) by Application (2013-2018)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2017
Table Astellas Pharma Basic Information List
Table Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018
Figure Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018
Figure Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Foresee Pharmaceuticals Basic Information List
Table Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2013-2018)
Figure Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2013-2018)
Figure Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Players in 2017
Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Drugs
Table Distributors/Traders List
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Price (USD/MT) and Trend Forecast (2018-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) Forecast by Regions (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) Forecast by Type (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Price (USD/MT) Forecast by Type (2018-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K MT) Forecast by Application (2018-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

前立腺肥大症(BPH)の治療薬、α遮断薬、ホスホジエステラーゼ5阻害薬、5α-リダクターゼ阻害剤、男性、女性

★調査レポート[前立腺肥大症(BPH)の治療薬の世界市場:販売動向2018] (コード:QYR80702186)販売に関する免責事項を必ずご確認ください。
★調査レポート[前立腺肥大症(BPH)の治療薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆